Characteristics of TraceTogether Users

Coronavirus Clinical Trial

Official title:

Characteristics of TraceTogether Users

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04468581
• Other study ID #: 510d
• Status: Completed
• Start date: April 3, 2020
• Est. completion date: July 17, 2020

Study information

• Verified date: December 2020
• Source: Yale-NUS College
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

In this protocol, we seek the understand the demographics of individuals who have used the TraceTogether mobile application. Little is known about the group of individuals who are more likely to utilise the application. Hence, this study hopes to: (1) Understand the demographics of Singaporeans who use and do not use TraceTogether, (2) Identify other behavioural habits of people who do use TraceTogether, (3) Determine if confidence in government would have any effect on TraceTogether usage

Recruitment information / eligibility

• Status: Completed
• Enrollment: 505
• Est. completion date: July 17, 2020
• Est. primary completion date: July 17, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 21 Years and older

Eligibility

Inclusion Criteria:

• At least 21 years

• Has stayed in Singapore for at least 2 years

Exclusion Criteria:

• Below 21 years

• Has stayed in Singapore for less than 2 years

Related Conditions & MeSH terms

• Coronavirus
• Coronavirus Infections

Intervention

Behavioral:
• Use of mobile application
Use of the TraceTogether mobile application during the COVID-19 period

Locations

Country	Name	City	State
Singapore	Yale NUS	Singapore

Sponsors (1)

Lead Sponsor	Collaborator
Yale-NUS College

Country where clinical trial is conducted

Singapore, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Demographic information	Age, gender, social economic status	Once during initial enrolment